Stock Report

Download full stock data and analysis for free Last Updated: 31-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Accretion Nutraveda Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 544694

₹281.90

up-down-arrow ₹-0.95 (-0.34%)

As on 28-Aug-2026IST

Market cap

info icon

₹204 Cr

Revenue (TTM)

info icon

₹34 Cr

P/E Ratio

info icon

40.3

P/B Ratio

info icon

6.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 110.00 126.21 --
EBIT -- -- 89.52 177.60 --
Net Profit -- -- 102.66 162.38 --
EPS -- -- 36.32 107.87 --
Book Value -- -- 320.31 290.75 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-26Mar-25Mar-24
EBIT-Margin info 20.29--19.7521.8819.23
Net Margin info 15.49--15.0315.6215.82
Return on equity info 77.04--27.6881.51121.94
Return on Capital info 43.28--30.1957.6642.00
Return on Assets info 23.75--19.3832.9718.90
Debt to Equity (x) info ----0.130.762.00

Profitability

View Detailed Peer Comparison

ROCE

30.19

Higher than Peers by 14.71

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
30.19
57.66
42.00
21.40
--
Peer Median
15.48
16.46
15.49
17.37
--
ROE

27.68

Higher than Peers by 15.00

Profit after tax / Average Net worth * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
27.68
81.51
121.94
106.65
--
Peer Median
12.68
13.87
14.72
15.70
--
ROA

19.38

Higher than Peers by 11.69

Profit after tax / Average Total assets * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
19.38
32.97
18.90
6.91
--
Peer Median
7.69
8.04
7.19
9.43
--
EBIT Margin

19.75

Higher than Peers by 4.06

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
19.75
21.88
19.23
10.69
--
Peer Median
15.68
10.05
10.28
13.90
--
Net Margin

15.03

Higher than Peers by 3.87

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
15.03
15.62
15.82
9.14
--
Peer Median
11.16
9.11
6.78
10.91
--
Cash Profit Margin

15.86

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
15.86
17.01
21.65
20.39
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

110.00

Higher than Peers by 94.95

Year on year growth in net sales

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
110.00
219.70
72.41
--
--
Peer Median
15.05
7.17
10.56
12.63
--
EBIT Growth

89.52

Higher than Peers by 69.63

Year on year growth in operating profit (EBIT)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
89.52
263.82
210.25
--
--
Peer Median
19.88
12.05
6.17
-2.90
--
Net Profit Growth

102.66

Higher than Peers by 83.54

Year on year growth in profit after tax

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
102.66
204.28
192.91
--
--
Peer Median
19.11
22.15
27.97
-14.10
--
EPS Growth

36.32

Higher than Peers by 13.21

Year on year growth in earnings per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
36.32
124.93
192.93
--
--
Peer Median
23.11
8.80
--
-3.68
--
Book Value Growth

524.85

--

Year on year growth in book value per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
524.85
365.66
312.35
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.13

Higher than Peers by 0.01

Total debt / Net worth

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
0.13
0.76
2.00
7.50
--
Peer Median
0.12
0.03
0.05
0.14
--
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
--
0.28
1.38
1.66
--
Peer Median
--
--
--
--
--
Current Ratio

11.98

Higher than Peers by 9.50

Current Assets / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
11.98
2.87
1.07
1.07
--
Peer Median
2.48
2.20
1.93
1.82
--
Quick Ratio

8.42

Higher than Peers by 6.60

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
8.42
1.36
0.29
0.53
--
Peer Median
1.82
1.72
1.59
1.30
--
Interest Coverage

12.57

Lower than Peers by 1.10

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
12.57
9.89
4.82
2.50
--
Peer Median
13.67
12.28
12.45
16.98
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

24.14

Lower than Peers by 6.51

Debtors outstanding / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
24.14
20.41
4.99
27.56
--
Peer Median
30.65
26.23
23.97
24.57
--
Asset Turnover

1.28

Higher than Peers by 0.58

Sales / Average Total Assets

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
1.28
2.11
1.15
0.72
--
Peer Median
0.70
0.74
0.88
0.82
--
Receivable days

61.80

--

Average Debtors / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
61.80
40.10
38.28
100.61
--
Peer Median
--
--
--
--
--
Inventory Days

73.78

--

Average Inventory / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
73.78
79.49
133.99
162.84
--
Peer Median
--
--
--
--
--
Payable days

12.43

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
12.43
30.77
161.86
354.92
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

123.15

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
123.15
88.82
10.41
-91.47
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

29.71

Lower than Peers by 25.36

Current share price divided by earning per share in the last twelve months

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
29.71
--
--
--
--
Peer Median
55.07
39.17
40.74
25.97
--
Price / Book Value

4.77

Higher than Peers by 0.01

Current share price divided by book value per share in the latest financial year

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
4.77
--
--
--
--
Peer Median
4.76
3.61
3.87
2.79
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
--
--
--
--
--
Peer Median
0.15
0.19
0.20
0.65
--
EV/EBITDA

20.70

Lower than Peers by 19.09

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
20.70
1.16
1.71
2.85
--
Peer Median
39.78
28.79
25.41
15.07
--
Market Cap

151

Lower than Peers by 5,669

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Accretion Nutraveda
151
--
--
--
--
Peer Median
5,820
3,944
2,959
3,742
--
loading...
loading...
loading...